StockData

Exicure, Inc. (XCUR) stock

XCURNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 4/30
$1.08+0.01 (+0.93%)

Close on Nov 17, 2026Market cap $7.07MP/E –Yield –

Exicure r&d expenses

Research and development expenses are spending on new products and technology.

Exicure's R&D Expenses for the twelve months ending Jun 30, 2026 was $2.03M, up 16.4% year over year. For fiscal 2025 it was $3.29M. The highest annual figure on record is $48.98M in fiscal 2021.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$3.29M–
FY2024Dec 31, 2024$0-100.0%
FY2023Dec 31, 2023$1.42M-92.8%
FY2022Dec 31, 2022$19.77M-59.6%
FY2021Dec 31, 2021$48.98M+52.6%
FY2020Dec 31, 2020$32.09M+65.9%
FY2019Dec 31, 2019$19.34M+37.0%
FY2018Dec 31, 2018$14.12M+7.9%
FY2017Dec 31, 2017$13.08M-4.2%
FY2016Dec 31, 2016$13.66M–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$174.00K-81.4%
Q1 FY2026Mar 31, 2026$312.00K-61.4%
Q4 FY2025Dec 31, 2025$655.00K–
Q3 FY2025Sep 30, 2025$888.00K–
Q2 FY2025Jun 30, 2025$935.00K–
Q1 FY2025Mar 31, 2025$808.00K–
Q4 FY2024Dec 31, 2024$0–
Q3 FY2024Sep 30, 2024$0–
Q2 FY2024Jun 30, 2024$0–
Q1 FY2024Mar 31, 2024$0-100.0%
Q4 FY2023Dec 31, 2023$0-100.0%
Q3 FY2023Sep 30, 2023$0-100.0%
Q2 FY2023Jun 30, 2023$0-100.0%
Q1 FY2023Mar 31, 2023$1.42M-80.1%
Q4 FY2022Dec 31, 2022$1.07M-90.6%
Q3 FY2022Sep 30, 2022$4.81M-70.8%
Q2 FY2022Jun 30, 2022$6.75M-37.8%
Q1 FY2022Mar 31, 2022$7.14M-30.4%
Q4 FY2021Dec 31, 2021$11.42M+15.7%
Q3 FY2021Sep 30, 2021$16.46M+80.1%
Q2 FY2021Jun 30, 2021$10.84M+54.7%
Q1 FY2021Mar 31, 2021$10.26M+68.9%
Q4 FY2020Dec 31, 2020$9.87M+19.4%
Q3 FY2020Sep 30, 2020$9.14M+115.3%
Q2 FY2020Jun 30, 2020$7.01M+104.1%
Q1 FY2020Mar 31, 2020$6.08M+78.9%
Q4 FY2019Dec 31, 2019$8.27M+174.8%
Q3 FY2019Sep 30, 2019$4.25M+6.1%
Q2 FY2019Jun 30, 2019$3.43M-10.5%
Q1 FY2019Mar 31, 2019$3.40M+3.7%
Q4 FY2018Dec 31, 2018$3.01M-5.1%
Q3 FY2018Sep 30, 2018$4.00M-24.9%
Q2 FY2018Jun 30, 2018$3.84M+58.9%
Q1 FY2018Mar 31, 2018$3.28M–
Q4 FY2017Dec 31, 2017$3.17M–
Q4 FY2016Dec 31, 2016$5.33M–
Q3 FY2016Sep 30, 2016$2.41M–

More Exicure figures

See a number that looks wrong?